ESR1 and hepatocellular carcinoma: Although the notion that estrogen and the estrogen receptor protect women from HCC, thus explaining the rising morbidity in post-menopausal women, and conversely that androgen and androgen receptors confer risk, the role of FTX in HCC, also related to HCC prognosis, and its higher expression in the female liver may contribute to cancer gender difference.